Meeting Banner
Abstract #2905

Use of Yb-HPDO3A probe for CEST-MRI pH mapping in glioblastoma mouse models

Giuseppe Ferrauto1, Michel Sarraf2, Enza Di Gregorio1, Vincent Auboiroux3, Ulysse Gimenez2, François Berger2, Silvio Aime1, and Hana Lahrech2

1Dept of Molecular Biotechnologies & Health Sciences, University of TORINO (IT), Torino, Italy, 2CLINATEC-CEA-INSERM UA01 – CHU –UJF Grenoble (FR), Grenoble, France, 3CLINATEC-CEA Grenoble (FR), Grenoble, France

MRI maps of extracellular/extravascular pH distribution in glioblastoma mouse model (U87 cells) have been obtained by administrating YbHPDO3A CEST probe. This molecule has potential in a clinical setting as it displays analogue properties (stability and in vivo pharmacokinetic) of its analogue clinically approved Gd-HPDO3A (ProHance). Furthermore, glioblastoma pH maps have been correlated with histology (H/E, Hif-1a and Ki-67 staining). The assessment of glioblastoma pHe could be used to monitor tumor development and to target acidic tumor regions using innovative responsive pH therapies.

This abstract and the presentation materials are available to members only; a login is required.

Join Here